ARCHIVES

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

October 21, 1988

Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website

August 8, 2014